Genmab A/S
Genmab A/S（GNMSF）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
gnmsf · 股价预测 · 11 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 11 位华尔街分析师
Buy
11 位分析师
共识
评级分布
12 个月目标价
High
$0.00
Consensus
$0.00
+0.0% upside
Low
$0.00
Median: $0 · Last Close: $249.45
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $239.30 | ↓ 4.07% |
1-day model range: $238.12–$240.48. Peak: $240.48 (-4.07%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $233 | -6.7% |
| 2028 | $223 | -10.7% |
| 2029 | $216 | -13.2% |
| 2030 | $213 | -14.8% |
| 2031 | — | -15.8% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · GNMSF · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2023-10-17 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-10-12 | BTIG | Maintains | Buy→Buy |
| 2023-09-25 | Truist Securities | Maintains | Buy→Buy |
| 2023-09-05 | Truist Securities | Maintains | Buy→Buy |
| 2023-09-04 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-08-14 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-08-03 | Morgan Stanley | Maintains | Underweight→Underweight |
| 2023-08-03 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-07-31 | Morgan Stanley | Maintains | Underweight→Underweight |
| 2023-07-30 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Genmab A/S (GNMSF) stock. Of the recent 71 rating actions, 2 were upgrades and 6 were downgrades. 11 analysts currently cover GNMSF.
分析师推荐趋势
GNMSF analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 2 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$4.3B
↓ 29.0% YoY
Revenue Next Year
$5.1B
↑ 17.1% YoY
EPS This Year
$11.51
EPS Next Year
$16.72
↑ 45.3% YoY
EPS ForecastReported vs Estimated
Analysts forecast GNMSF EPS of $11.51 for the current fiscal year, based on estimates from 10 analysts. The GNMSF revenue forecast is $4.3B for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
GNMSF 股价预测由两类独立数据源支撑：来自 11 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。GNMSF 的共识目标价为 $0.00（+0.0% 上行空间），分析师共识为 Buy。
GNMSF 的短期预测（明日）为 $239.30（-4.07%）。 GNMSF 对 2027 年的股价预测均值为 $233。 GNMSF 对 2030 年的预测区间为 $201–$224。
Genmab A/S 在 OTC 上市，代码 GNMSF。GNMSF 在 2027 年的整体展望偏积极，在覆盖分析师中约 55% 对应 Buy 共识。
常见问题
GNMSF 预测 · 8 个问题根据 11 位华尔街分析师，GNMSF 的 12 个月平均目标价为 $0.00，最高 $0.00、最低 $0.00。若有图表，中位目标价可在上方查看。相对当前价 $249.45，隐含约 +0.0% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.